Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines

ASEM 문헌 요약

Official National Advisory Committee on Immunization document (2020) on “Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines”. Flucelvax® Quad is a mammalian cell culture-based, inactivated seasonal influenza vaccine that has recently been authorized for use in Canada in adults and children ≥9 years of age.

이 요약은 문서를 식별하는 데 도움이 됩니다. 임상 권고사항은 항상 공식 버전과 업데이트 날짜를 확인하십시오.